Merck KGaA (FRA:MRK) received a €115.00 ($135.29) price target from investment analysts at Kepler Capital Markets in a research note issued to investors on Wednesday. The brokerage presently has a “buy” rating on the healthcare company’s stock.

MRK has been the subject of several other research reports. Goldman Sachs Group, Inc. (The) set a €105.00 ($123.53) target price on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Tuesday, September 19th. Citigroup Inc. set a €123.00 ($144.71) price target on shares of Merck KGaA and gave the stock a “buy” rating in a research report on Monday, September 25th. DZ Bank AG reissued a “sell” rating on shares of Merck KGaA in a research report on Tuesday, July 18th. Warburg Research set a €116.00 ($136.47) price target on shares of Merck KGaA and gave the company a “neutral” rating in a report on Friday, July 7th. Finally, Commerzbank Ag set a €109.00 ($128.24) price target on shares of Merck KGaA and gave the company a “neutral” rating in a report on Wednesday, September 6th. Thirteen analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of €109.43 ($128.75).

Shares of Merck KGaA (MRK) opened at 96.52 on Wednesday. The firm has a market capitalization of €41.96 billion and a price-to-earnings ratio of 25.16. The stock’s 50 day moving average price is €94.77 and its 200-day moving average price is €101.91. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00.

TRADEMARK VIOLATION NOTICE: This article was published by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/10/04/merck-kgaa-mrk-pt-set-at-115-00-by-kepler-capital-markets.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.